Clinical Trials Directory

Trials / Completed

CompletedNCT02191527

Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique

Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services and Their Impact on Mother and Child Health Outcomes in Cabo Delgado Province, Mozambique

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,673 (actual)
Sponsor
Elizabeth Glaser Pediatric AIDS Foundation · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The general goal of the proposed study is to evaluate the cost-effectiveness of POC technologies for diagnosis of syphilis, quantitative analysis for hemoglobin and CD4 counting performed within MCH services to improve maternal and infant health. A prospective, quasi-experimental study will be done in Cabo Delgado province, where health facilities will be randomized in an intervention or comparison arm. Outcomes on maternal and infant health will be measured.

Conditions

Interventions

TypeNameDescription
DEVICEPIMA® for quantitative analysis of CD4-count
DEVICEHemocue® (HemoCue AB, Angelhom, Sweden) for quantitative analysis of hemoglobin
DEVICESD Bioline® (Standard Diagnostics Inc., South-Korea) for qualitative analysis of syphilis

Timeline

Start date
2013-09-01
Primary completion
2014-10-01
Completion
2015-02-01
First posted
2014-07-16
Last updated
2020-07-23

Source: ClinicalTrials.gov record NCT02191527. Inclusion in this directory is not an endorsement.